Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy


Creative Commons License

Erdogan D., Güllü H., ÇALIŞKAN M. , Çiftçi Ö., Baycan S., Yıldırır A., et al.

HEART, cilt.93, ss.319-324, 2007 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 93 Konu: 3
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1136/hrt.2006.091751
  • Dergi Adı: HEART
  • Sayfa Sayısı: ss.319-324

Özet

Background: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC). Nebivolol reduces mortality and morbidity in patients with heart failure and left ventricular dysfunction, including cases caused by IDC.